J. Reblando

Health Care CBA/CEA: An Update on the Growth and Composition of the Literature

W. R. Taylor, A. Elixhauser, B. Luce, 1993, Medical care.

Patient-reported utilization patterns of fentanyl transdermal system and oxycodone hydrochloride controlled-release among patients with chronic nonmalignant pain.

M. Mordin, J. Reblando, J. Schein, 2003, Journal of managed care pharmacy : JMCP.

Health-related quality of life effects of modafinil for treatment of narcolepsy.

A E Rogers, A. Rogers, J. Reblando, 1999, Sleep.

The accuracy of self-reported disability days.

G. E. Simon, D. Revicki, J. Reblando, 1994, Medical care.

Patient-Reported Utilization Patterns of Fentanyl Transdermal System and Oxycodone Hydrochloride Controlled-Release Among Patients With Chronic Nonmalignant Pain

M. Mordin, J. Reblando, J. Schein, 2003, Journal of managed care pharmacy : JMCP.

Acute Medical Costs of Fluoxetine versus Tricyclic Antidepressants

D. Revicki, J. Reblando, K. Kulig, 2012, PharmacoEconomics.